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Abstract
Background:  In previous studies, the relaxant, anticholinergic (functional antagonism) and
antihistaminic effects of Nigella sativa have been demonstrated on guinea pig tracheal chains. To
elucidate the other mechanisms responsible for the relaxant effect of this plant, its inhibitory effect
on the calcium channel was examined in this study.
Results:  The inhibitory effects of both concentrations of diltiazem in all three groups of
experiments were significantly greater than those of saline (p < 0.01 to P < 0.001). The inhibitory
of two larger concentrations of aqueous extracts in group 1 and 2 were significantly greater than
those of saline (p < 0.01 to P < 0.001). The effect of two larger concentrations of macerated extract
in group 1 and all concentrations of this extract in group 2 were also significantly greater than those
of saline (p < 0.01 to P < 0.001). However, the extract of Nigella sativa did not show any inhibitory
effect in group 3. There was a significant correlation between inhibitory effect and increasing
concentrations for both extracts and diltiazem in groups 1 and 2 (p < 0.05 to p < 0.005).
Conclusion: Although the extracts of Nigella sativa showed inhibitory effects on pre-contracted
tracheal chains in the presence of both ordinary and calcium free Krebs solution, the absence of
inhibitory effects of the extracts on KCl induced contraction of tracheal chains suggest that the
calcium channel blocking effect of this plant dose not contribute to the relaxant effect of this plant
on the tracheal chains of guinea pigs.
Background
Nigella sativa L. (Ranunculaceae) is a grassy plant with
green to blue flowers and small black seeds, which grows
in temperate and cold climate areas. The seeds of Nigella
sativa  contain thymoquinone, monotropens such as p-
cymene and α-pinene [1], Nigellidine [2], Nigellimine [3]
and a saponin [4].
Several therapeutic effects including those on digestive
disorders, gynaecology, and also anti-asthma and dyspnea
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have been described for the seeds of Nigella sativa in
ancient Iranian medical books [5]. Nigella sativa has long
been known for its medical use as an antispasmodic, espe-
cially against gastrointestinal disorders or respiratory ail-
ments, in many countries.
There is evidence of relaxant effects of volatile oil from
this plant on different smooth muscle including rabbit
aorta [6], rabbit jejunum [7], and isolated tracheal mus-
cles of guinea pigs [8]. Mahfous and El-Dakhakhny
(1960) reported that the volatile oil from Nigella sativa
protected guinea pigs against histamine-induced bron-
chospasm, but it did not affect histamine H1 receptors in
isolated tissues [9]. However, in an in vivo study, increas-
ing respiratory rate and intra tracheal pressure of guinea
pigs due to i.v. administration of volatile oil from Nigella
sativa has been demonstrated [10]. In our recent studies, a
relaxant effect for this plant was shown [11]. In addition
the anticholinergic, and histamine H1 receptor blocking
effects of this plant on isolated guinea pig tracheal chains
were demonstrated by performing concentration response
curves to methacoline and histamine in the presence of
saline and plant extracts [11,12]. In both studies the plant
extracts caused rightward shift in concentration response
curves to methacoline and histamine.
To elucidate the other mechanism(s) responsible for the
observed bronchodilatory effect of Nigella sativa, the
inhibitory effect of aqueous and macerated extracts of this
plant on the calcium channel of guinea pig tracheal chains
was examined in this study.
Results
Inhibitory effect
In group 1 experiments the inhibitory effects of 5 µM con-
centration of diltiazem and 0.5 g% and 1 g% concentra-
tions of both extracts were significantly greater than that
of saline (p < 0.05 to p < 0.001, Table1). In group 2 exper-
iments the inhibitory effect of both concentrations of
diltiazem, all concentrations of macerated extract and 0.5
g% and 1 g% concentrations of aqueous extracts were sig-
nificantly greater than the effect of saline (p < 0.5 to p <
0.001, Table 1). In group 3 experiments only both con-
centrations of diltiazem showed significant inhibitory
effect compared to saline (p < 0.001 for both cases, Table
1).
Differences between the effect of diltiazem and extracts
There was no significant difference between the effects of
extracts from Nigella sativa with those of diltiazem in
group 1 and 2 experiments. However, the effects of all
concentrations of aqueous and macerated extracts were
significantly lower than those of diltiazem in group 3 (p <
0.001 for all cases).
Differences of the inhibitory effects between three groups 
of experiments
The inhibitory effects of all concentrations of macerated
extract in group 2 and those of diltiazem in groups 2 and
3 were significantly greater than the effects obtained in
group 1 (p < 0.05 to p < 0.001, Fig 1). The inhibitory
effects of all concentrations of aqueous extract in group 2
were also non-significantly greater than those of group 1
(Fig 1). However, the inhibitory effects of all concentra-
tions of extracts in group 3 were significantly lower than
those of group 1 and 2 experiments (p < 0.001 for all
cases, Fig 1).
Relationship between concentrations and inhibitory effect
In group 1, only the inhibitory effect of 0.25 g% vs 1 g%
aqueous extract was statistically significant (p < 0.05).
However, in group 2, the differences in inhibitory effects
between all concentrations of two extracts except that of
0.5 g% vs 1 g% macerated extract were significant (p <
0.05 to p < 0.001). The inhibitory effects of two concen-
trations of diltiazem were also significantly different in
group 2 and 3 (p < 0.05 and p < 0.001 respectively). In
addition there were significant correlations between
increasing concentrations and inhibitory effects for both
extracts in group 1 and 2 experiments (p < 0.05 to p <
0.005, Table 2).
Discussion
The bronchodilatory effect seen for Nigella sativa in our
previous study [11] might be produced due to several dif-
ferent mechanisms. With regard to bronchodilatory effect
of calcium channel blockers [13,14], one possible mecha-
nism responsible for the bronchodilatory effect of this
plant could be the inhibitory effect of this plant on cal-
cium channels. This effect of the aqueous and macerated
extracts from Nigella sativa was therefore examined on iso-
lated guinea pig tracheal preparations in the present
study.
In group 1 experiments (contracted tracheal chains by 10
µM methacholine in the presence of ordinary Krebs solu-
tion) both extracts and diltiazem showed concentration-
dependent inhibitory effects compared with that of saline.
To examine whether the inhibitory effects of extracts seen
in group 1 were due to inhibitory effect on calcium chan-
nels or not, the inhibitory effects of extracts and diltiazem
were re-examined on contracted tracheal chains in the
presence of calcium-free Krebs solution in group 2. The
results of this group also showed concentration-depend-
ent inhibitory effects of both extracts and diltiazem on
methacholine-induced contraction of tracheal chains.
With regard to the inhibitory effect of KCl on calcium
channels [15], the inhibitory effects of differentBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/3
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concentrations of extracts and diltiazem were also exam-
ined on KCl induced contraction of tracheal chains (group
3 experiments). In this group of experiments extracts from
Nigella sativa did not show any inhibitory effect on KCl
induced contraction. However, diltiazem showed concen-
tration-dependent inhibitory effect on KCl induced con-
traction of tracheal chains.
Although, the results of group 1, and mainly group 2, may
indicate an inhibitory effect of the extracts from Nigella
sativa as claimed in a previous study [16]. However, the
results of group 3 clearly showed that the extracts from
this plant have no inhibitory effects on calcium channels
of guinea pig tracheal chains. The cause for methacholine
induced contraction of tracheal chains in group 2 is
unclear to us, but the most probable explanation is the
role of stored calcium in smooth muscle cytoplasm in this
phenomenon. A previous study also showed contraction
of tracheal smooth muscle in the presence of calcium-free
Krebs solution [16]. The mechanism of inhibitory effect of
diltiazem on methacholine induced contraction of tra-
cheal chains in the presence of calcium free buffer (group
2) is perhaps due to inhibition of increase in sarcoplasmic
calcium concentration released from sarcoplasmic reticu-
lum through IP3 induced calcium release [17].
In our previous study a rightward shift of concentration-
response curves of CaCl2 in tracheal chains of guinea pigs
has been demonstrated for aqueous extract of Nigella
sativa, indicating a calcium channel inhibitory effect of
this extract [18]. However, the results of the present study
showed that aqueous and macerated extracts have no
inhibitory effect on calcium channels. The cause of right-
ward shift in CaCl2 concentration-response curves of our
previous study [18] may be due to the relaxant effect of
this plant on tracheal chains.
While KCl affects calcium channels [15] and with regard
to bronchodilatory effects of calcium channel blockers
[13,14], these findings showed the absence of a blocking
effect of the extracts from  Nigella sativa on calcium chan-
nels. The absence of obvious relaxant effects of aqueous
and macerated extracts from this plant in group 3 and the
relatively potent relaxant effect of this extract in groups 1
and 2 experiments may also indicate an opening effect of
these extracts on potassium channels because the bron-
chodilatory effects of potassium channel opening has
been demonstrated previously [19]. If the aqueous and
macerated extracts from Nigella sativa had a potassium
channel opening effect, they would not have relaxant
effects on tracheal chains contracted by KCl, while they
could show relaxant effect when the tracheal chain was
contracted by methacholine. In fact, the results of groups
1 and 2 may support this effect of aqueous and macerated
extracts. Therefore, the absence of inhibitory effects of
Inhibitory effect of different concentrations of aqueous and  macerated extracts from Nigella sativa, diltiazem, and saline  on pre-contracted tracheal chains of guinea pigs. Figure 1
Inhibitory effect of different concentrations of aqueous and 
macerated extracts from Nigella sativa, diltiazem, and saline 
on pre-contracted tracheal chains of guinea pigs. group 1 
(methacholine induced contraction of guinea pig tracheal 
chains in the presence of ordinary Krebs solution, blue col-
our), group 2 (methacholine induced contraction of guinea 
pig tracheal chains in the presence of calcium free Krebs 
solution, green colour) and group 3 (KCl induced contrac-
tion of guinea pig tracheal chains in the presence of ordinary 
Krebs solution, red colour). (a) low concentration, (b) 
medium concentration, and (c) high concentration, for 
diltiazem only 2 concentrations (low and medium) were 
examined. Statistical differences between the results of group 
1 with those of group 2 and 3; NS: non significant difference 
*: p < 0.05, **: p < 0.01, ***: p < 0.001. Statistical differences 
between the results of group 2 with those of group 3, +: p < 
0.05, ++: p < 0.01, +++: p < 0.001. Aqueous and macerated 
extracts did not show any inhibitory effect in group 3 experi-
ments compared to the effect of saline.
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extracts in group 3 experiments may suggest the absence
of any effects on calcium channels and/or existence of an
opening effect of potassium channels for these extracts
from  Nigella sativa. However, multiple substances may
present in the extracts leading to its pharmacological
effects. The extracts may contain one or more substances
affecting calcium channels, but their effects are masked by
other substances. Therefore, the calcium channel inhibi-
tory effects of different fractions should be tested in future
studies.
Although both aqueous and macerated extracts are aque-
ous in nature, the methods of extraction for the two
extracts are different. For preparing aqueous extract the
seed should be exposed to water steam (100°C) for 18–24
h. But for macerated extract it should be macerated with
water at room temperature for 48 h while shaking inter-
mittently. Therefore the ingredients of two extracts may be
different. In aqueous extract more substances may be
extracted, but some ingredients are destroyed due to the
high temperature. However, the effect of two extract was
not statistically different.
The cause of a small contraction effect of saline in all 3
groups and extracts in group 3 is presumably the continu-
ous effects of the contractile substances (methacholine or
KCl). Therefore, whenever extracts and diltiazem show
inhibitory properties, they also inhibit this slight concen-
tration effect.
The results of our previous studies [11,12] and present
study suggest that anticholinergic, histamine H1 inhibi-
tory, and probable potassium channel opening effects of
Nigella Sativa may contribute to the bronchodilatory effect
of this plant. The other possible mechanisms responsible
for the bronchodilatory effect of Nigella sativa are as fol-
low: stimulation of β-adrenegic receptors [20], stimula-
tion of inhibitory non-adrenergic non-cholinergic
nervous system (NANC) or inhibition of stimulatory
NANC [21], methylxanthine activity of the plant [22], and
inhibition of phosphodiesterase [23]. The contribution of
these mechanisms and the importance of those seen in
our studies in the bronchodilatory effects of Nigella sativa
should be clarified in further studies. In the present study
only direct in vitro effective concentrations are shown and
examined. Therefore to discover the applied effective con-
Table 1: Inhibitory effect of three cumulative concentrations of aqueous and macerated extracts from Nigella sativa, two concentrations 
of diltiazem and saline in three groups of experiments on pre-contracted tracheal chain of guinea pigs.
Inhibitory effect
Experimental 
design
Group 1 St.Dif vs S. St. Dif vs D Group 2 St.Dif vs S. St. Dif vs D. Group 3 St.Dif vs S. St. Dif vs D.
Sline 1 ml -2.43 ± 0.90 -1.93 ± 0.74 -0.83 ± 1.35
Diltiazem 1 µM 12.72 ± 2.80 NS 34.30 ± 2.02 P < 0.01 58.57 ± 8.36 P < 0.001
5 µM 19.67 ± 6.00 P < 0.05 62.67 ± 9.62 P < 0.001 90.71 ± 6.21 P < 0.001
Aqueous extract 0.25 g% 15.23 ± 3.80 NS NS 19.16 ± 4.59 NS NS -2.24 ± 0.75 NS P < 0.001
0.5 g% 22.87 ± 3.66 P < 0.05 NS 35.56 ± 7.99 P < 0.01 NS -1.85 ± 0.60 NS P < 0.001
1 g% 35.65 ± 10.45 P < 0.001 47.58 ± 8.67 P < 0.001 -1.56 ± 0.55 NS
Macerate extract 0.25 g% 16.20 ± 2.67 NS NS 25.53 ± 1.67 P < 0.05 NS -2.50 ± 0.80 NS P < 0.001
0.5 g% 21.50 ± 4.26 P < 0.05 NS 41.06 ± 5.98 P < 0.001 NS -1.70 ± 0.65 NS P < 0.001
1 g% 28.80 ± 5.26 P < 0.001 52.67 ± 8.07 P < 0.001 -1.65 ± 0.7 NS
Values are presented as percentage change in proportion to maximum contraction obtained due to contractile agents and quoted as mean ± SEM. 
Group 1: experiments on tracheal chains contracted by 10 µM methacholine in the presence of ordinary Krebs solution. Group 2: experiments on 
tracheal chains contracted by 10 µM methacholine in the presence of calcium free Krebs solution. Group 3: experiments on tracheal chains 
contracted by 60 mM KCl in the presence of ordinary Krebs solution (for each group, n = 6). St. Dif: Statistical difference, NS: non significant 
difference, S: saline, D: diltiazem.
Table 2: Correlation between the inhibitory effects of extracts from Nigella sativa with concentrations in groups 2 and 3 experiments.
Aqueous extract Macerated extract
Experimental Groups R p value R P value
Group 1 0.49 p < 0.05 0.48 P < 0.05
Group 2 0.558 p < 0.05 0.62 P < 0.005BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/3
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centrations or dosages of the extract more in vivo studies
are required which is clearly dependent upon the admin-
istration route. In addition, the fractionation of the
extracts and study of effective fraction are also needed for
this purpose.
In conclusion, the results of the present study show that
although the extracts of Nigella sativa showed inhibitory
effects on pre-contracted tracheal chains in the presence of
both ordinary and calcium free Krebs solutions, the
absence of inhibitory effect of the extracts on KCl induced
contraction of tracheal chains suggest that aqueous and
macerated extracts have no inhibitory effect on calcium
channels. Therefore, the calcium channel blocking effect
of this plant dose not contribute to the relaxant effect of
this plant on tracheal chains of guinea pigs. However, the
results of this study suggested a potassium channel open-
ing effect for the extracts from Nigella sativa that may con-
tribute on the relaxant effect of this plant on tracheal
chains of guinea pigs.
Material and Methods
Plant and extracts
Nigella sativa was collected from Torbat Heydarieh (north
east Iran) in the spring of 2002, and dried at room temper-
ature in the absence of sunlight. The plant was identified
by botanists in the herbarium of Ferdowsi University of
Mashhad; and the specimen number of the plant is 293-
0303-1 Nigella sativa
The aqueous extract was prepared as follows: Fifty grams
of the chopped, dried plant was extracted with 300 ml dis-
tilled water by suxhelat apparatus. Three hundred millili-
tres distilled water were added to a glass balloon in the
lower part of suxhelat apparatus which was over a heater.
The heater was set to boil distilled water continuously.
The water steam flow through the middle part of the appa-
ratus contained plant powder. The steam was then cooled
and converted to liquid as it passed through a tube in the
upper portion of the suxhelat with a helix tube inside
through which tap water flowed. By means of aside tube,
then added to the balloon in the lower part. This proce-
dure was continued for 18–24 h until the liquid water
returning to balloon through the side tube became col-
ourless. For macerated extract, the same amount of plant
was macerated with 300 ml distilled water (on a shaker)
for 48 hr. The solvent of both extracts were then removed
under reduced pressure until the extract volumes reached
20 ml. Plant ingredient concentration in the final extracts
was 10% W/W in both extracts. The amount of thymoqui-
none, thymohydroquinone and thymol in the essential
oil of Nigella sativa is 0.53 %, 0.77 % and 0.91 % respec-
tively [24]. However, there is no information regarding
the amount of main constituents in aqueous and macer-
ated extracts of this plant but their amount in extracts
seems to be lower than in the essential oil.
Tissue preparations
Male guinea pigs (400–700 g) were killed by a blow on
the neck and trachea removed. Each trachea was cut into
10 rings (each containing 2–3 cartilaginous rings). All the
rings were then cut open opposite the trachealis muscle,
and sutured together to form a tracheal chain [25].
Tissue was then suspended in a 10 ml organ bath (organ
bath 61300, Bio Science Palmer-Washington, Sheerness,
Kent U.K.) containing Krebs-Henseleit solution of the fol-
lowing composition (mM): NaCl 120, NaHCO3  25,
MgSO4 0.5, KH2PO4 1.2, KCl 4.72 and dextrose 11.
The Krebs solution was maintained at 37°C and gassed
with 95 % O2 and 5 % CO2. Tissue was suspended under
an isotonic tension of 1 g and allowed to equilibrate for at
least 1 h while it was washed with Krebs solution every 15
min.
Protocols
The inhibitory effect of three different concentrations of
aqueous and macerated extracts from Nigella sativa (0.25
g%, 0.5 g%, and 1 g% from each extract) and two concen-
trations of diltiazem (1 and 5 µM) in comparison with
negative control (saline, 1 ml) on calcium channels was
examined. To produce three concentrations of each extract
0.25 ml, 0.25 ml, and 0.5 ml of 10 W/V concentrated
extract and for diltiazem 0.1 and 0.4 ml of 10 mM concen-
trated solution were added on a 10 ml organ bath at 5 min
intervals.
In each experiment the effect of three cumulative concen-
trations from each extract, two cumulative concentrations
of diltiazem or saline on contracted tracheal smooth mus-
cle were measured after exposing tissue to the solution for
10 min. A decrease in tone was considered as an inhibi-
tory effect and expressed as positive percentage change in
proportion to maximum contraction obtained due to con-
tractile agents.
The inhibitory effects of different solutions were tested
with three different experimental designs as follows:
1. On tracheal chains contracted by 10 µM methacholine
hydrochloride in the presence of ordinary Krebs solution
(Sigma Chemical Ltd UK), (group 1 experiments).
2. On tracheal chains contracted by 10 µM methacholine
hydrochloride in the presence of calcium free Krebs solu-
tion (group 2 experiments).Publish with BioMed Central    and   every 
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3. On tracheal chains contracted by 60 mM KCl in the
presence of ordinary Krebs solution (group 3
experiments).
The inhibitory effects in three groups of experiments were
examined in three different series of tracheal chains (for
all groups, n = 6). All of the experiments were performed
randomly with a 1 h resting period of tracheal chains
between each two experiments while washing the tissues
every 15 min with Krebs solution. In all experiments
responses were recorded on a kymograph (ET8 G-Boulitt,
Paris) and were measured after fixation. The study was
approved by the ethical committee of Mashhad University
of Medical Sciences.
Statistical analysis
The data of the inhibitory effect of different experiments
were expressed as mean ± SEM. The data of inhibitory
effects of different concentrations of extracts, diltiazem,
and saline were compared using ANOVA test in each
group. The effect of each concentration of extracts and
diltiazem between three groups was also compared using
ANOVA. The inhibitory effect of different extracts were
related to the concentrations of the solutions using least
square regression. Significance was accepted at p < 0.05.
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